We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Who Should Receive Clozapine?

Stephen R. Marder, MD; Theodore Van Putten, MD
Arch Gen Psychiatry. 1988;45(9):865-867. doi:10.1001/archpsyc.1988.01800330099012.
Text Size: A A A
Published online


Soon after clinical studies of clozapine were initiated— more than 25 years ago—it was apparent that the drug was at least as effective as available neuroleptics and resulted in negligible extrapyramidal side effects. It was hoped that the widespread availability of the drug would represent a major innovation in the treatment of schizophrenia. These hopes were dealt a severe blow when the drug was found to be associated with a relatively high rate of agranulocytosis. This resulted in the drug being severely restricted in its use in some countries and unavailable in others (including the United States, where it has been given to only a limited number of patients under humanitarian use protocols or in carefully monitored investigations).

Because of this toxic effect, the Food and Drug Administration requested data indicating that clozapine is more See also p 789. effective than conventional neuroleptics in patients considered resistant to treatment. This


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.